ARCHIVES

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP Last Month

November 25, 2011

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Final Issues Of 1982

December 10, 1982

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007